Compound heterozygous or homozygous truncating MYBPC3 mutations cause lethal cardiomyopathy with features of noncompaction and septal defects.

MLA

Wessels, Marja W., et al. “Compound Heterozygous or Homozygous Truncating MYBPC3 Mutations Cause Lethal Cardiomyopathy with Features of Noncompaction and Septal Defects.” European Journal of Human Genetics : EJHG, vol. 23, no. 7, July 2015, pp. 922–28. EBSCOhost, https://doi.org/10.1038/ejhg.2014.211.

APA

Wessels, M. W., Herkert, J. C., Frohn-Mulder, I. M., Dalinghaus, M., van den Wijngaard, A., de Krijger, R. R., Michels, M., de Coo, I. F., Hoedemaekers, Y. M., & Dooijes, D. (2015). Compound heterozygous or homozygous truncating MYBPC3 mutations cause lethal cardiomyopathy with features of noncompaction and septal defects. European Journal of Human Genetics : EJHG, 23(7), 922–928. https://doi.org/10.1038/ejhg.2014.211

Chicago

Wessels, Marja W, Johanna C Herkert, Ingrid M Frohn-Mulder, Michiel Dalinghaus, Arthur van den Wijngaard, Ronald R de Krijger, Michelle Michels, Irenaeus Fm de Coo, Yvonne M Hoedemaekers, and Dennis Dooijes. 2015. “Compound Heterozygous or Homozygous Truncating MYBPC3 Mutations Cause Lethal Cardiomyopathy with Features of Noncompaction and Septal Defects.” European Journal of Human Genetics : EJHG 23 (7): 922–28. doi:10.1038/ejhg.2014.211.